Skip to main content
. 2017 Apr 1;18(3):250–272. doi: 10.1089/sur.2016.200

Table 5.

Studies of Hyperbaric Oxygen in Necrotizing Soft Tissue Infections and Sepsis

Author Study design Population Sample size Control Intervention Adjustment Mortality or survival (HBO vs. none)
Meta-analyses/systematic reviews
Levett et al. (2015) Meta-analysis All n = 673 studies reviewed; 0 studies included N/A Not described N/A Not described
Wang et al. (2003) Systematic review All n = 17 studies for gas gangrene; n = 9 progressive necrotizing infection N/A n = 4 observational studies, 13 case series: 2–3 ATM, 4 to 44 tx; N = 6 observational studies, 3 case series: 2–3 ATM, usually 90 min/tx, for 5–7 tx N/A For gas gangrene, summary estimates could not be derived; for progressive necrotizing infection, there may be of benefit; in general, very difficult to generate conclusion because of poor quality of studies
Observational trials
Shaw et al. (2014) Retrospective, multiple centers (n = 14), UHC Predominantly Type I (FG, NF, gas gangrene) 1,583 n = 1,466 n = 117, not described Yes, multi-variable In-hospital survival: aOR 10.6 (5.2–25.1); 95% vs. 88%, p = 0.028
Li et al. (2014) Retrospective Type I (FG) 28 n = 12 n = 16, 2.5 ATM, 90–120 min/tx, twice daily None In-hospital survival: 14/16 (87.5%) vs. 8/12(66%), p < 0.05
Massey et al. (2012) Retrospective Mixed as extremity and perineum 80 n = 48 n = 32, 2.8 ATM, 45 min/tx, 1–8 treatments None In-hospital survival: 84.4% vs. 81.2%, p = 0.77; no difference by location in perineum or extremity
Mehl et al. (2010) Retrospective, single center Predominantly Type I (FG, NF, gas gangrene) 40 n = 14 n = 26, 2.0–2.8 ATM, 120 min/tx, 6–20 tx None In-hospital survival: 23/26 (88.5%) vs. 9/14 (64.3%), p = 0.07
Hassan et al. (2010) Retrospective, single center Not determined 67 n = 38 n = 29 None NS
Wolf et al. (2010) Retrospective, single center Head and neck 17 n = 4 n = 13, not described None In-hospital: 17/17(100%) for entire cohort
George et al. (2009) Retrospective, comparison of 2 centers Type I (FG, mixed, poly-microbial) in 36%; Type II (strep) in 28%; Type III (clostridial in 5 patients) 78 n = 30 n = 48, 3 ATM, 90 min/tx, 3 tx/d then 2 tx/d, until infection resolved Yes, multi-variable 44/48 (91.7%) vs. 26/30 (86.7%), p = 0.48; aOR 0.98 (0.18–5.42)
Krenk et al. (2007) Retrospective, single center Head and neck 19 n = 7 n = 11, 2.8 ATM, 90 min/tx, 2–3 dives/day, until no necrosis None In-hospital survival: 11/11 (1005) vs. 2/8(25%), p < 0.001
Ayan et al. (2005) Retrospective, single center Type 1 (FG) 41 n = 23 n = 18, 2.5 ATM, 90 min/d, 3–10 d of treatment None In-hospital survival: 18/18 (100%) vs. 14/23 (61%), p = 0.013
Mindrup et al. (2005) Retrospective, single center Type 1 (FG) 42 n = 16 n = 26, 2.4–3 ATM, 30–90 min/tx, 1–3 dives/day, 2–26 treatments None In-hospital survival: 19/26 (72.1%) vs. 14/16 (87.5%), p = 0.44
Sugihara et al. (2004) Retrospective, single center Not described, assumed to be all types 23 n = 9 n = 14, 2.5 ATM, 90 min/tx, unknown daily frequency, until symptoms resolved None Not described
Wilkinson et al. (2004) Retrospective, single center Type I (FG, mixed, poly-microbial) 44 n = 11 n = 33, 2.8 ATM, 60 min/tx, 3 tx/d then 2 tx/d, until infection resolved Yes, multi-variable In-hospital survival: 31/33 (94%) vs. 7/11 (64%), p = 0.03, univariable; aOR 8.9 (1.3–58)
Hollabaugh et al. (1998) Retrospective, single center Predominantly Type I (FG, NF, gas gangrene) 26 n = 12 n = 12, 2.4 ATM, 90 min/tx, 2 tx/d for at least 7 d, then until therapy terminated None 13/14 (93%) vs. 7/12 (58%), p = 0.04; aOR 11, no 95% CI or p value provided
Shupak et al. (1997) Retrospective, single center ? 37 n = 12 n = 25; 2.5 ATM, 45 min/t, 2 t/d, until infection resolved None In-hospital survival: 9/25 (67%) vs. 3/12 (75%), p = 0.71

HBO = hyperbaric oxygen; NA = not available; ATM = atmospheres; UHC = __________; FG = Fournier gangrene; NF = necrotizing fasciitis; aOR = adjusted odds ratio; CI = confidence interval.